BUSINESS
Miracle aging treatment Botox set to face fight from this little-known Indian firm
BSE-listed Gulfic Biosciences has received approvals to manufacture and sell Botulinum toxin, better known by popular brand name Botox.
BUSINESS
Why Biocon's 10 cents insulin offer could be a game changer in fighting diabetes
Currently, blended median patient prices in LMICs are $9 per 10 ml vial translating to 36 US cents per day
BUSINESS
Apollo Hospitals to focus on cutting debt, improving operational performance
"We are bringing down the debt from Rs 3300 crore to Rs 2500 crore by the end of the financial year," said Suneeta Reddy, Managing Director of Apollo Hospitals to Moneycontrol.
BUSINESS
GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos
Sources within pharma industry told Moneycontrol that Dr Reddy’s and Saraca Laboratories are two big suppliers of the Ranitidine active pharmaceutical ingredient (API) globally, from which most other companies source the API to formulate the drug.
BUSINESS
A look at how InnAccel is trying to save patients from Ventilator Acquired Pneumonia
Coeo Labs, a division of InnAccel, has developed an indigenous device called VAPCare, which automates the manual process of secretion clearance and oral cleansing performed by nurses.
BUSINESS
SEBI imposes penalties of Rs 22.7 crore on Aurobindo Pharma, promoters on insider trading charges
SEBI asked the Aurobindo and its promoters to pay the penalty within 45 days of the receipt of the order.
BUSINESS
Siemens Healthineers to make India its manufacturing hub
The company, which has invested Rs 2,500 crore in its research and development (R&D) centre in Bengaluru, has also opened a new manufacturing plant with a capex of Rs 20 crore.
BUSINESS
Weekly wrap: Philippines polio outbreak; why India can't afford to be complacent
The polio outbreak in the Philippines is confirmed to be from a circulating vaccine-derived poliovirus type 2.
BUSINESS
Make in India? Indian companies sit on Japanese encephalitis vaccine capacities for years, as govt imports Chinese vaccine
“The Chinese company which built huge capacities has been dumping the vaccine 20-30 cents to a dollar in India per dose, we couldn’t compete at that price,” said a top executive from one of the vaccine company mentioned in the story.
BUSINESS
Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma
The Strides board on September 20 approved an additional investment up to $40 million in Stelis, over a period of 24 months for the purpose.
BUSINESS
Slowdown blues: Mega summits to woo investments take a hit as investors get cold feet
The government had to cancel two such mega events recently.
BUSINESS
E-cigarettes banned: What led government to terminate ENDS?
The ordinance proposes maximum imprisonment of up to one year along with a fine of Rs 1 lakh for first-time violators, and imprisonment of upto 3 yrs & fine upto Rs 5 lakh for subsequent offences.
BUSINESS
Pharmacy retail chain MedPlus eyes foray into Mumbai market
MedPlus in Mumbai will be pitted against Wellness Forever and Apollo Pharmacy -the largest - along with numerous other mom and pop chemist shops.
BUSINESS
Exclusive | TPG Capital still in hunt to buy hospitals in India after Medanta deal fell through
The private equity firm plans to invest $500 million-$1 billion yearly
BUSINESS
A look at how Foreign OPD is trying to redefine the medical second-opinion space
Different doctors often have different ways of treating the same illness. A second medical opinion can expose a patient to a broader range of treatment options.
BUSINESS
Pharma wrap: Ranitidine carcinogen impurity scare and rising problem of drug contamination
USFDA has detected low level of a cancer-causing impurity in samples of commonly used heartburn or acidity medicine Ranitidine
BUSINESS
Lupin exploring in-licensing deals to expand neuro-psychiatry, oncology segments
The company is exploring new product offerings for treating multiple sclerosis, migraine, Parkinson's, and Alzheimer's diseases.
BUSINESS
Here is why horse breeding is the secret behind success of Cyrus Poonawalla's vaccine business
With a net worth of $13 billion, Poonawalla is the fourth richest person in India and 100th in the world, according to Hurun Global Rich List - 2019.
BUSINESS
Is the END in sight for e-cigarettes?
The ordinance called as the “Prohibition of E-cigarettes Ordinance 2019" is being vetted by a Group of Ministers (GoM) comprising of the finance minister as well as health, commerce, agriculture, chemicals and petrochemicals and the food processing ministries.
BUSINESS
Pharma wrap: Purdue Pharma settlement, US opioid crisis and lessons for India
US-based Purdue Pharma and its owners, the Sackler family, have offered to settle over 2,000 lawsuits against the company for $10 billion to $12 billion, reports suggest
BUSINESS
US opioid crisis and India's own drug problems
US has been waging a war against drugs, pharmaceutical companies and their executives who are pushing these drugs to doctors through inducements.
BUSINESS
TPG's Asia Healthcare Holdings acquires Nova IVI Fertility chain for undisclosed amount
Nova fertility operates India’s second largest network of IVF centres with 20 centres across 15 cities.
BUSINESS
Donation of TB drug bedaquiline based on Indian govt's request to USAID: J&J
The specific India donation from J&J sparked questions from public health groups and activists about the timing and intent of J&J.
BUSINESS
How SIRO Clinpharm is trying to regain its lost glory on favourable conditions
SIRO Clinpharm is trying to make a comeback on rising offshoring of clinical trials in India by global drug makers
